Lionco Pharm Grp Co Ltd (603669) — Capital Reinvestment Ratio
Lionco Pharm Grp Co Ltd (603669) has a Capital Reinvestment Ratio of 0.68x as of September 2023, meaning it reinvests 1% of its operating cash flow (CN¥7.06 Million) in capital expenditures (CN¥4.78 Million). See 603669 net asset quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Lionco Pharm Grp Co Ltd Capital Reinvestment Ratio (2011–2021)
This chart tracks Lionco Pharm Grp Co Ltd's Capital Reinvestment Ratio across 11 annual periods. Check 603669 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Lionco Pharm Grp Co Ltd (2011–2021)
Year-by-year Capital Reinvestment Ratio for Lionco Pharm Grp Co Ltd from 2011 to 2021. For live market cap and broader valuation context, see Lionco Pharm Grp Co Ltd stock valuation.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2021 | 0.43x | CN¥128.50 Million | CN¥54.82 Million | ▼ -12.7% |
| 2020 | 0.49x | CN¥126.81 Million | CN¥61.95 Million | ▲ +959.1% |
| 2019 | 0.05x | CN¥235.61 Million | CN¥10.87 Million | ▼ -95.1% |
| 2018 | 0.93x | CN¥185.87 Million | CN¥173.70 Million | ▲ +104.0% |
| 2017 | 0.46x | CN¥189.01 Million | CN¥86.57 Million | ▼ -6.1% |
| 2016 | 0.49x | CN¥182.27 Million | CN¥88.94 Million | ▼ -31.2% |
| 2015 | 0.71x | CN¥98.88 Million | CN¥70.10 Million | ▲ +10.3% |
| 2014 | 0.64x | CN¥181.50 Million | CN¥116.70 Million | ▼ -0.6% |
| 2013 | 0.65x | CN¥160.77 Million | CN¥103.97 Million | ▼ -15.9% |
| 2012 | 0.77x | CN¥142.61 Million | CN¥109.64 Million | ▲ +205.3% |
| 2011 | 0.25x | CN¥98.23 Million | CN¥24.74 Million | — |